Structure

Physi-Chem Properties

Molecular Weight:  428.22
Volume:  449.573
LogP:  4.222
LogD:  3.399
LogS:  -4.035
# Rotatable Bonds:  8
TPSA:  107.22
# H-Bond Aceptor:  6
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.456
Synthetic Accessibility Score:  3.422
Fsp3:  0.48
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.8
MDCK Permeability:  1.7664924598648213e-05
Pgp-inhibitor:  0.175
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.013
20% Bioavailability (F20%):  0.179
30% Bioavailability (F30%):  0.006

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.019
Plasma Protein Binding (PPB):  97.6697769165039%
Volume Distribution (VD):  0.596
Pgp-substrate:  1.5800890922546387%

ADMET: Metabolism

CYP1A2-inhibitor:  0.596
CYP1A2-substrate:  0.815
CYP2C19-inhibitor:  0.534
CYP2C19-substrate:  0.065
CYP2C9-inhibitor:  0.563
CYP2C9-substrate:  0.951
CYP2D6-inhibitor:  0.836
CYP2D6-substrate:  0.844
CYP3A4-inhibitor:  0.681
CYP3A4-substrate:  0.182

ADMET: Excretion

Clearance (CL):  11.791
Half-life (T1/2):  0.862

ADMET: Toxicity

hERG Blockers:  0.039
Human Hepatotoxicity (H-HT):  0.191
Drug-inuced Liver Injury (DILI):  0.038
AMES Toxicity:  0.106
Rat Oral Acute Toxicity:  0.041
Maximum Recommended Daily Dose:  0.385
Skin Sensitization:  0.847
Carcinogencity:  0.101
Eye Corrosion:  0.003
Eye Irritation:  0.167
Respiratory Toxicity:  0.04

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472907

Natural Product ID:  NPC472907
Common Name*:   XVCXFWODDIZFKK-UHFFFAOYSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  XVCXFWODDIZFKK-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C25H32O6/c1-24(2,30)12-4-13-25(3)14-11-18-16(6-10-21(28)23(18)31-25)5-9-20(27)19-8-7-17(26)15-22(19)29/h6-8,10,15,26,28-30H,4-5,9,11-14H2,1-3H3
SMILES:  CC1(CCC2=C(C=CC(=C2O1)O)CCC(=O)C3=C(C=C(C=C3)O)O)CCCC(C)(C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3593940
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003467] Linear 1,3-diarylpropanoids
        • [CHEMONTID:0001630] Chalcones and dihydrochalcones
          • [CHEMONTID:0003473] 2'-Hydroxy-dihydrochalcones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33150 Artocarpus communis Species Moraceae Eukaryota heartwood n.a. n.a. PMID[16643064]
NPO28799 Hyptis suaveolens Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[19299148]
NPO33150 Artocarpus communis Species Moraceae Eukaryota roots Khon Kaen, Thailand 2009-DEC PMID[25537111]
NPO33150 Artocarpus communis Species Moraceae Eukaryota n.a. n.a. n.a. PMID[26178912]
NPO28799 Hyptis suaveolens Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[26178912]
NPO28799 Hyptis suaveolens Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO28799 Hyptis suaveolens Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28799 Hyptis suaveolens Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO28799 Hyptis suaveolens Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 36700.0 nM PMID[456288]
NPT610 Others Molecular identity unknown IC50 = 29500.0 nM PMID[456288]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472907 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9933 High Similarity NPC472963
0.9865 High Similarity NPC472905
0.9673 High Similarity NPC472964
0.9671 High Similarity NPC474960
0.9669 High Similarity NPC136674
0.9542 High Similarity NPC472902
0.9542 High Similarity NPC471973
0.953 High Similarity NPC151473
0.9481 High Similarity NPC472906
0.9477 High Similarity NPC476242
0.9477 High Similarity NPC235448
0.9474 High Similarity NPC274730
0.9474 High Similarity NPC24640
0.947 High Similarity NPC49402
0.947 High Similarity NPC33051
0.947 High Similarity NPC273462
0.947 High Similarity NPC469550
0.947 High Similarity NPC227337
0.947 High Similarity NPC70433
0.9423 High Similarity NPC293319
0.9419 High Similarity NPC201800
0.9416 High Similarity NPC36217
0.9416 High Similarity NPC139036
0.9416 High Similarity NPC200746
0.9416 High Similarity NPC320359
0.9412 High Similarity NPC300727
0.9412 High Similarity NPC129684
0.9412 High Similarity NPC187745
0.9412 High Similarity NPC474681
0.9412 High Similarity NPC241904
0.9412 High Similarity NPC161960
0.9412 High Similarity NPC299520
0.9412 High Similarity NPC304008
0.9412 High Similarity NPC67876
0.9412 High Similarity NPC218313
0.9408 High Similarity NPC472280
0.9408 High Similarity NPC256925
0.9408 High Similarity NPC57674
0.9408 High Similarity NPC67396
0.9408 High Similarity NPC152951
0.9408 High Similarity NPC117992
0.9408 High Similarity NPC230149
0.9408 High Similarity NPC234255
0.9408 High Similarity NPC168247
0.9404 High Similarity NPC257648
0.9404 High Similarity NPC237994
0.9404 High Similarity NPC477231
0.9404 High Similarity NPC260979
0.9404 High Similarity NPC472912
0.94 High Similarity NPC29231
0.9396 High Similarity NPC196277
0.9396 High Similarity NPC43669
0.9396 High Similarity NPC272721
0.9363 High Similarity NPC39091
0.9359 High Similarity NPC186686
0.9359 High Similarity NPC189473
0.9359 High Similarity NPC23298
0.9355 High Similarity NPC40491
0.9355 High Similarity NPC61010
0.9355 High Similarity NPC278052
0.9355 High Similarity NPC234644
0.9351 High Similarity NPC474290
0.9351 High Similarity NPC210459
0.9351 High Similarity NPC204879
0.9351 High Similarity NPC55738
0.9351 High Similarity NPC280680
0.9351 High Similarity NPC100123
0.9346 High Similarity NPC115853
0.9346 High Similarity NPC470600
0.9346 High Similarity NPC472455
0.9346 High Similarity NPC133970
0.9346 High Similarity NPC6633
0.9346 High Similarity NPC5322
0.9342 High Similarity NPC89474
0.9342 High Similarity NPC18727
0.9338 High Similarity NPC31363
0.9338 High Similarity NPC154345
0.9329 High Similarity NPC77378
0.9304 High Similarity NPC218226
0.9299 High Similarity NPC303174
0.9299 High Similarity NPC239752
0.9299 High Similarity NPC472450
0.9299 High Similarity NPC275780
0.9295 High Similarity NPC329760
0.9295 High Similarity NPC25152
0.929 High Similarity NPC470183
0.929 High Similarity NPC56085
0.929 High Similarity NPC228785
0.929 High Similarity NPC299436
0.929 High Similarity NPC188433
0.929 High Similarity NPC321399
0.929 High Similarity NPC14353
0.9286 High Similarity NPC27337
0.9286 High Similarity NPC291508
0.9286 High Similarity NPC273843
0.9286 High Similarity NPC180011
0.9286 High Similarity NPC219867
0.9286 High Similarity NPC111969
0.9286 High Similarity NPC52889
0.9286 High Similarity NPC236796
0.9281 High Similarity NPC200246
0.9281 High Similarity NPC255807
0.9281 High Similarity NPC31018
0.9276 High Similarity NPC236637
0.9276 High Similarity NPC39732
0.9276 High Similarity NPC60972
0.9276 High Similarity NPC302950
0.9276 High Similarity NPC219582
0.9272 High Similarity NPC85131
0.9241 High Similarity NPC37870
0.9241 High Similarity NPC43319
0.9241 High Similarity NPC477517
0.9241 High Similarity NPC472449
0.9236 High Similarity NPC236521
0.9236 High Similarity NPC7483
0.9236 High Similarity NPC236132
0.9236 High Similarity NPC248638
0.9236 High Similarity NPC152659
0.9236 High Similarity NPC475985
0.9236 High Similarity NPC220313
0.9231 High Similarity NPC471210
0.9231 High Similarity NPC57715
0.9231 High Similarity NPC472634
0.9231 High Similarity NPC167678
0.9231 High Similarity NPC474187
0.9231 High Similarity NPC29876
0.9226 High Similarity NPC74178
0.9226 High Similarity NPC184755
0.9221 High Similarity NPC291878
0.9221 High Similarity NPC142339
0.9221 High Similarity NPC472626
0.9221 High Similarity NPC209614
0.9221 High Similarity NPC195796
0.9221 High Similarity NPC475799
0.9221 High Similarity NPC13779
0.9221 High Similarity NPC138243
0.9221 High Similarity NPC472916
0.9221 High Similarity NPC474638
0.9221 High Similarity NPC470328
0.9221 High Similarity NPC471985
0.9221 High Similarity NPC278778
0.9221 High Similarity NPC191146
0.9221 High Similarity NPC68093
0.9221 High Similarity NPC35038
0.9216 High Similarity NPC141212
0.9216 High Similarity NPC206238
0.9216 High Similarity NPC292214
0.9216 High Similarity NPC167091
0.9216 High Similarity NPC271779
0.9216 High Similarity NPC88645
0.9211 High Similarity NPC202157
0.9211 High Similarity NPC251110
0.9205 High Similarity NPC48479
0.9205 High Similarity NPC223579
0.9205 High Similarity NPC287101
0.9205 High Similarity NPC105512
0.9205 High Similarity NPC183950
0.9205 High Similarity NPC177298
0.9205 High Similarity NPC137062
0.9205 High Similarity NPC52005
0.92 High Similarity NPC168803
0.92 High Similarity NPC95864
0.9182 High Similarity NPC476306
0.9177 High Similarity NPC475888
0.9172 High Similarity NPC474034
0.9172 High Similarity NPC211107
0.9172 High Similarity NPC474162
0.9172 High Similarity NPC474033
0.9172 High Similarity NPC474150
0.9172 High Similarity NPC83922
0.9172 High Similarity NPC472448
0.9172 High Similarity NPC229632
0.9167 High Similarity NPC472630
0.9167 High Similarity NPC472624
0.9167 High Similarity NPC476980
0.9167 High Similarity NPC192686
0.9167 High Similarity NPC80375
0.9167 High Similarity NPC472631
0.9167 High Similarity NPC119209
0.9167 High Similarity NPC475886
0.9167 High Similarity NPC118256
0.9167 High Similarity NPC235018
0.9167 High Similarity NPC119224
0.9167 High Similarity NPC45146
0.9167 High Similarity NPC204290
0.9167 High Similarity NPC474287
0.9161 High Similarity NPC471515
0.9161 High Similarity NPC469584
0.9161 High Similarity NPC48208
0.9161 High Similarity NPC471479
0.9161 High Similarity NPC181960
0.9161 High Similarity NPC96167
0.9161 High Similarity NPC472598
0.9161 High Similarity NPC474208
0.9161 High Similarity NPC472913
0.9161 High Similarity NPC162869
0.9161 High Similarity NPC474836
0.9161 High Similarity NPC165977
0.9161 High Similarity NPC474055
0.9161 High Similarity NPC472914

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472907 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9276 High Similarity NPD1934 Approved
0.9091 High Similarity NPD2393 Clinical (unspecified phase)
0.9091 High Similarity NPD2801 Approved
0.9 High Similarity NPD1511 Approved
0.8974 High Similarity NPD3882 Suspended
0.8882 High Similarity NPD1512 Approved
0.882 High Similarity NPD6168 Clinical (unspecified phase)
0.882 High Similarity NPD6167 Clinical (unspecified phase)
0.882 High Similarity NPD6166 Phase 2
0.8726 High Similarity NPD7819 Suspended
0.872 High Similarity NPD7074 Phase 3
0.8659 High Similarity NPD7054 Approved
0.8608 High Similarity NPD1465 Phase 2
0.8606 High Similarity NPD7472 Approved
0.8598 High Similarity NPD3818 Discontinued
0.8562 High Similarity NPD7075 Discontinued
0.8553 High Similarity NPD3817 Phase 2
0.8543 High Similarity NPD1549 Phase 2
0.8537 High Similarity NPD7473 Discontinued
0.85 High Similarity NPD4868 Clinical (unspecified phase)
0.8491 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8477 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8477 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8466 Intermediate Similarity NPD6232 Discontinued
0.8457 Intermediate Similarity NPD5494 Approved
0.8452 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8452 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8418 Intermediate Similarity NPD4380 Phase 2
0.8393 Intermediate Similarity NPD7251 Discontinued
0.8344 Intermediate Similarity NPD1510 Phase 2
0.8343 Intermediate Similarity NPD7808 Phase 3
0.8333 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD6797 Phase 2
0.8333 Intermediate Similarity NPD3749 Approved
0.8323 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD5844 Phase 1
0.8322 Intermediate Similarity NPD943 Approved
0.8322 Intermediate Similarity NPD1240 Approved
0.8312 Intermediate Similarity NPD3750 Approved
0.8289 Intermediate Similarity NPD2796 Approved
0.8269 Intermediate Similarity NPD6799 Approved
0.8235 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8212 Intermediate Similarity NPD1607 Approved
0.8187 Intermediate Similarity NPD6599 Discontinued
0.8182 Intermediate Similarity NPD6959 Discontinued
0.8182 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.817 Intermediate Similarity NPD6099 Approved
0.817 Intermediate Similarity NPD6100 Approved
0.8137 Intermediate Similarity NPD7411 Suspended
0.8086 Intermediate Similarity NPD6801 Discontinued
0.8084 Intermediate Similarity NPD3926 Phase 2
0.8054 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD3748 Approved
0.7987 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7956 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD7768 Phase 2
0.7929 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7871 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7861 Intermediate Similarity NPD6559 Discontinued
0.7857 Intermediate Similarity NPD7199 Phase 2
0.7848 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7844 Intermediate Similarity NPD919 Approved
0.7843 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7843 Intermediate Similarity NPD1613 Approved
0.7792 Intermediate Similarity NPD447 Suspended
0.7791 Intermediate Similarity NPD3226 Approved
0.7785 Intermediate Similarity NPD2800 Approved
0.7778 Intermediate Similarity NPD5403 Approved
0.7771 Intermediate Similarity NPD2346 Discontinued
0.7771 Intermediate Similarity NPD2344 Approved
0.7771 Intermediate Similarity NPD5402 Approved
0.7765 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7764 Intermediate Similarity NPD2534 Approved
0.7764 Intermediate Similarity NPD2532 Approved
0.7764 Intermediate Similarity NPD2533 Approved
0.7753 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7751 Intermediate Similarity NPD1247 Approved
0.7736 Intermediate Similarity NPD4628 Phase 3
0.7733 Intermediate Similarity NPD3751 Discontinued
0.7712 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7707 Intermediate Similarity NPD1551 Phase 2
0.7707 Intermediate Similarity NPD2935 Discontinued
0.7684 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7677 Intermediate Similarity NPD230 Phase 1
0.7677 Intermediate Similarity NPD1933 Approved
0.7673 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD5401 Approved
0.7647 Intermediate Similarity NPD4625 Phase 3
0.7647 Intermediate Similarity NPD3027 Phase 3
0.7643 Intermediate Similarity NPD2799 Discontinued
0.7633 Intermediate Similarity NPD6234 Discontinued
0.7602 Intermediate Similarity NPD3787 Discontinued
0.76 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD7390 Discontinued
0.7593 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD2309 Approved
0.7562 Intermediate Similarity NPD1243 Approved
0.7529 Intermediate Similarity NPD7228 Approved
0.7516 Intermediate Similarity NPD6651 Approved
0.7516 Intermediate Similarity NPD9494 Approved
0.75 Intermediate Similarity NPD1203 Approved
0.7472 Intermediate Similarity NPD8312 Approved
0.7472 Intermediate Similarity NPD8313 Approved
0.7468 Intermediate Similarity NPD4908 Phase 1
0.7458 Intermediate Similarity NPD7685 Pre-registration
0.7451 Intermediate Similarity NPD2798 Approved
0.744 Intermediate Similarity NPD37 Approved
0.7416 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD4967 Phase 2
0.7412 Intermediate Similarity NPD4966 Approved
0.7412 Intermediate Similarity NPD4965 Approved
0.741 Intermediate Similarity NPD1653 Approved
0.7407 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7401 Intermediate Similarity NPD5953 Discontinued
0.7386 Intermediate Similarity NPD7286 Phase 2
0.7386 Intermediate Similarity NPD1470 Approved
0.7372 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD3268 Approved
0.7372 Intermediate Similarity NPD2313 Discontinued
0.7372 Intermediate Similarity NPD3764 Approved
0.7368 Intermediate Similarity NPD4749 Approved
0.7363 Intermediate Similarity NPD4287 Approved
0.7362 Intermediate Similarity NPD6190 Approved
0.7355 Intermediate Similarity NPD6832 Phase 2
0.7353 Intermediate Similarity NPD4288 Approved
0.7351 Intermediate Similarity NPD1610 Phase 2
0.7351 Intermediate Similarity NPD1201 Approved
0.7351 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD920 Approved
0.7348 Intermediate Similarity NPD8150 Discontinued
0.7348 Intermediate Similarity NPD8434 Phase 2
0.7317 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD4308 Phase 3
0.7303 Intermediate Similarity NPD9717 Approved
0.7303 Intermediate Similarity NPD1608 Approved
0.7299 Intermediate Similarity NPD5710 Approved
0.7299 Intermediate Similarity NPD5711 Approved
0.7287 Intermediate Similarity NPD6779 Approved
0.7287 Intermediate Similarity NPD6780 Approved
0.7287 Intermediate Similarity NPD6778 Approved
0.7287 Intermediate Similarity NPD6777 Approved
0.7287 Intermediate Similarity NPD6776 Approved
0.7287 Intermediate Similarity NPD6781 Approved
0.7287 Intermediate Similarity NPD6782 Approved
0.7273 Intermediate Similarity NPD2797 Approved
0.7267 Intermediate Similarity NPD5405 Approved
0.7267 Intermediate Similarity NPD5406 Approved
0.7267 Intermediate Similarity NPD5404 Approved
0.7267 Intermediate Similarity NPD5408 Approved
0.7263 Intermediate Similarity NPD7435 Discontinued
0.7262 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD5242 Approved
0.7254 Intermediate Similarity NPD8151 Discontinued
0.7229 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD1471 Phase 3
0.7219 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD7033 Discontinued
0.72 Intermediate Similarity NPD7229 Phase 3
0.7197 Intermediate Similarity NPD7095 Approved
0.719 Intermediate Similarity NPD9269 Phase 2
0.7173 Intermediate Similarity NPD7698 Approved
0.7173 Intermediate Similarity NPD7697 Approved
0.7173 Intermediate Similarity NPD7696 Phase 3
0.717 Intermediate Similarity NPD4060 Phase 1
0.716 Intermediate Similarity NPD7458 Discontinued
0.7152 Intermediate Similarity NPD2354 Approved
0.7152 Intermediate Similarity NPD411 Approved
0.7152 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD5353 Approved
0.715 Intermediate Similarity NPD7584 Approved
0.7135 Intermediate Similarity NPD7870 Phase 2
0.7135 Intermediate Similarity NPD7871 Phase 2
0.7133 Intermediate Similarity NPD5536 Phase 2
0.7125 Intermediate Similarity NPD6355 Discontinued
0.7125 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD422 Phase 1
0.712 Intermediate Similarity NPD6823 Phase 2
0.7119 Intermediate Similarity NPD2403 Approved
0.7113 Intermediate Similarity NPD7701 Phase 2
0.7112 Intermediate Similarity NPD4360 Phase 2
0.7112 Intermediate Similarity NPD4363 Phase 3
0.7105 Intermediate Similarity NPD17 Approved
0.7092 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7092 Intermediate Similarity NPD7783 Phase 2
0.7091 Intermediate Similarity NPD8166 Discontinued
0.7086 Intermediate Similarity NPD1548 Phase 1
0.7078 Intermediate Similarity NPD3972 Approved
0.7076 Intermediate Similarity NPD6386 Approved
0.7076 Intermediate Similarity NPD6385 Approved
0.7072 Intermediate Similarity NPD7240 Approved
0.707 Intermediate Similarity NPD3018 Phase 2
0.7066 Intermediate Similarity NPD4357 Discontinued
0.7063 Intermediate Similarity NPD4307 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data